KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Net Cash Flow: 2017-2025

Historic Net Cash Flow for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to -$18.6 million.

  • Twist Bioscience's Net Cash Flow fell 43.65% to -$18.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$43.9 million, marking a year-over-year increase of 27.25%. This contributed to the annual value of -$43.9 million for FY2025, which is 27.25% up from last year.
  • According to the latest figures from Q3 2025, Twist Bioscience's Net Cash Flow is -$18.6 million, which was down 107.81% from -$9.0 million recorded in Q2 2025.
  • In the past 5 years, Twist Bioscience's Net Cash Flow registered a high of $216.0 million during Q1 2022, and its lowest value of -$274.2 million during Q4 2021.
  • In the last 3 years, Twist Bioscience's Net Cash Flow had a median value of -$11.2 million in 2025 and averaged -$12.1 million.
  • In the last 5 years, Twist Bioscience's Net Cash Flow soared by 327.75% in 2022 and then crashed by 1,324.52% in 2024.
  • Twist Bioscience's Net Cash Flow (Quarterly) stood at -$274.2 million in 2021, then skyrocketed by 77.60% to -$61.4 million in 2022, then soared by 66.99% to -$20.3 million in 2023, then soared by 75.25% to -$5.0 million in 2024, then tumbled by 43.65% to -$18.6 million in 2025.
  • Its last three reported values are -$18.6 million in Q3 2025, -$9.0 million for Q2 2025, and -$11.2 million during Q1 2025.